Alterna ventures into nail fungal solutions under Kerasal foot care brand
WHIPPANY, N.J. — Alterna earlier this week launched Kerasal Nail – Fungal Nail Renewal Treatment, a topical formula clinically proven to improve appearance of nails damaged or discolored by fungus and psoriasis.
In a consumer research study of 500 fungal nail suffers, 77% said they would definitely or probably buy Kerasal Nail after seeing the concept. Alterna has dedicated $5 million in advertising and promotion to launch Kerasal Nail to the U.S. market, with heavy focus on television, print and consumer promotion. The company expects to add at least $10 million of incremental retail sales to the category annually.
An estimated 30 million Americans suffer from unsightly nail appearance, a market currently underserved by nonprescription products. Kerasal Nail’s unique nail-penetrating formula has been licensed exclusively for the U.S. market from Moberg Derma, a Swedish pharmaceutical company. The product already is the No. 1 seller in various European countries where it launched last year, Alterna reported.
In the most recent clinical study, more than 90% of users saw improvement in nail appearance after eight weeks, and more than 75% saw improvement in appearance in just two weeks of use.
Kerasal Nail’s patented formula combines the keratolyctic, nail softening and hydrating effects of propylene glycol, urea and lactic acid to deeply penetrate the nail and restore healthy appearance by normalizing thickened nails, reducing nail discoloration and hydrating brittle nails. Kerasal Nail is odorless and preservative free.
The product will be found on store shelves in the foot care aisles in major Walmart stores and Rite Aid stores this fall.